Tagomics is a Cambridge-based biotechnology company developing a next-generation multi-omic biomarker discovery platform to transform the way disease and drug safety are understood, measured, and monitored. Originating from pioneering research by Dr Robert Neely and colleagues at the University of Birmingham, our proprietary technology integrates genetic, epigenetic, and fragmentomic features from circulating cell‑free DNA. Combined with advanced bioinformatics and machine learning, it enables deep biological insight across applications ranging from early cancer detection to drug safety and organ health monitoring. We are building the production‑grade engineering platform for our first products and are expanding our multidisciplinary team at Babraham Research Campus, one of Europe’s leading life‑science hubs.

The Role

We are seeking a proactive and highly organised Laboratory and Facility Manager to oversee the day‑to‑day operations of our scientific facilities ...